Table 1.
Species | Phenotypes/markers | Relevance to disorders/modelsa | References |
---|---|---|---|
Mice | CD19+CD5+CD1dhi | CHS, EAE | Matsushita et al., 2008; Yanaba et al., 2008 |
CD1dhiCD21hiCD23−CD24hiIgMhiIgDlo | IBD | Wei et al., 2005 | |
TIM‐1+B | EAE | Ding et al., 2011 | |
CD1dhiCD21hiCD23+CD24hilgMhiIgD+ | Experimental arthritis | Evans et al., 2007 | |
CD19+CD25+B220+ | Breast cancer | Olkhanud et al., 2011 | |
Human | CD19+CD5+CD1dhi | NMO, CHB, CHC | Wang et al., 2014a; Yang et al., 2015 |
CD19+CD5+Foxp3+ | Normal subjects | Noh et al., 2010 | |
CD19+CD24hiCD27+ | cGVHD, RA, SS, SLE | Iwata et al., 2011; Daien et al., 2014; de Masson et al., 2015 | |
CD19+CD25+ | MS | de Andres et al., 2014 | |
CD19+CD38+CD1d+IgM+CD147+ | Solid tumors | Lindner et al., 2013 | |
CD5+CD24hiCD38hi | AAV | Aybar et al., 2015 | |
CD19+CD24hiCD38hi | MS, NMO, SLE, RA, SS, pemphigus, ITP, AAV | Blair et al., 2010; Furuzawa‐Carballeda et al., 2013; Wilde et al., 2013; Daien et al., 2014; Hua et al., 2014; Zhu et al., 2015 |
CHS, contact hypersensitivity; IBD, inflammatory bowel disease; CHB, chronic hepatitis B; CHC, chronic hepatitis C; cGVHD, chronic graft versus host disease; RA, rheumatoid arthritis; SS, primary Sjogren's syndrome; AAV, ANCA‐associated vasculitis; ITP, immune thrombocytopenia.